Eden Biodesign will produce Stealthyx Therapeutics' lead therapeutic candidate. Stealthyx is evaluating for treatment of a range of inflammatory diseases including rheumatoid arthritis.
Eden Biodesign
Thursday 6 March 2008
Eden in manufacturing deal with Stealthyx
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment